Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Total 13F shares
-
137,366,906
-
Share change
-
+3,272,309
-
Total reported value
-
$1,007,015,553
-
Put/Call ratio
-
39%
-
Price per share
-
$7.33
-
Number of holders
-
195
-
Value change
-
+$22,122,148
-
Number of buys
-
91
-
Number of sells
-
72
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q1 2025
As of 31 Mar 2025 OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) had 195 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 137,366,906 shares of stock of the company.
Largest 10 holders included Deep Track Capital, LP, Summer Road LLC, VR ADVISER, LLC, BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, TCG Crossover Management, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 195 institutional shareholders of the security as of 31 Mar 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.